L-arginine role for stone lower ureter: A randomized controlled trial
Urolithiasis · 11.06.2025 · 53 (1)
DOI: 10.1007/s00240-025-01768-3 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Urolithiasis, online erschienen am 11.06.2025. Verfasst von Ahmed Mahmoud Mohammed Ahmed Elsherief und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sohag University, Sohag, Egypt. ahmed-mahmoud@med.sohag.edu.eg. Hauptthemen laut MEDLINE: Ureteral Calculi, Arginine, Sulfonamides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sohag University.
Abstract (Originalsprache)
This study aims to evaluate the effects of L-arginine 1000 mg once daily as a medical expulsive therapy (MET) for lower ureteral stones. This prospective, randomized controlled study was conducted on 162 patients with ureteral stones; 9 patients were excluded due to loss to follow-up, and the remaining 153 patients were divided into three groups. Group I (control) included 51 patients who received a placebo. Group II included 51 patients who received 1000 mg of L-arginine once daily. Group III included 51 patients who received tamsulosin 0.4 mg once daily. There was a highly statistically significant difference between the studied groups regarding ultrasound (U/S) and plain urinary tract (PUT) findings after 4 weeks. Spontaneous stone expulsion rates (SER) in the control, L-arginine, and tamsulosin groups were 6 (11.8%), 48 (94.1%), and 16 (31.4%), respectively ( p < 0.001). The mean ± SD of stone expulsion time in the control, L-arginine, and tamsulosin groups was 19.6 ± 5.85, 19.02 ± 5, and 20.58 ± 5.78 days, respectively ( p < 0.001). There was no statistically significant difference between the groups regarding the number of daily colic episodes and total analgesic dosage required. However, a statistically significant difference was noted regarding stone density and hydronephrosis. It is concluded that L-arginine is more effective than tamsulosin in increasing the SER and reducing stone expulsion time, with better pain control, making it a safe and effective MET for ureteral stones.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sohag University, Sohag, Egypt. ahmed-mahmoud@med.sohag.edu.eg.
- Sohag University, Sohag, Egypt.
- Aswan University, Aswān, Egypt.
Förderung
- Sohag University
Zitieren
APA
Mahmoud Mohammed Ahmed Elsherief, A., Mahmoud Riyad, A., Abdellah Ali, E., Alam-Eldin Ahmed, A., Ali Gad, H., & Mamdouh Abd Elhameid, A. (2025). L-arginine role for stone lower ureter: A randomized controlled trial. Urolithiasis, 53(1). https://doi.org/10.1007/s00240-025-01768-3
Vancouver
Mahmoud Mohammed Ahmed Elsherief A, Mahmoud Riyad A, Abdellah Ali E, Alam-Eldin Ahmed A, Ali Gad H, Mamdouh Abd Elhameid A. L-arginine role for stone lower ureter: A randomized controlled trial. Urolithiasis. 2025;53(1). doi:10.1007/s00240-025-01768-3
BibTeX
@article{MahmoudMohammedAhmedElsherief2025,
author = {Mahmoud Mohammed Ahmed Elsherief, Ahmed and Mahmoud Riyad, Ahmed and Abdellah Ali, Emad and Alam-Eldin Ahmed, Amr and Ali Gad, Hassan and Mamdouh Abd Elhameid, Ahmed},
title = {L-arginine role for stone lower ureter: A randomized controlled trial},
journal = {Urolithiasis},
year = {2025},
volume = {53},
number = {1},
doi = {10.1007/s00240-025-01768-3}
}
EUVIMED